QUINCE THERAPEUTICS INC (QNCX:NASDAQ)

$1.15 -0.02 (-1.7094%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 64

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed QUINCE THERAPEUTICS INC (QNCX:NASDAQ) News Sources

Quince Therapeutics Presents Safety Data from Long-Term eDSP Treatment in Children with Ataxia-Telangiectasia at British Paediatric Neurology Association Annual Meeting

28-01-2026

yahoo.com

Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia

29-01-2026

yahoo.com

Spotify upgraded, Pinterest downgraded: Wall Street's top analyst calls

30-01-2026

yahoo.com

Quince Therapeutics’ stock crashes on Phase III ataxia-telangiectasia failure

02-02-2026

clinicaltrialsarena.com

Quince Therapeutics Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Alternatives

09-02-2026

yahoo.com

BC-Most Active Stocks

05-03-2026

yahoo.com

Quince Therapeutics Settles Approximately $16.4 Million of Debt

30-03-2026

yahoo.com

Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline

18-05-2026

yahoo.com

Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD

18-05-2026

yahoo.com

UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD

18-05-2026

yahoo.com

QUINCE THERAPEUTICS INC (QNCX:NASDAQ) Sentiment Trend

0 25 50 75 100 82 89 2 3 85 87 75 86 65 65 28-01-2026 29-01-2026 30-01-2026 02-02-2026 09-02-2026 05-03-2026 30-03-2026 18-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

QUINCE THERAPEUTICS INC (QNCX:NASDAQ) FAQs

toggle

What is the current price of QUINCE THERAPEUTICS INC (QNCX:NASDAQ)?

The current price of QUINCE THERAPEUTICS INC (QNCX:NASDAQ) is $1.15.


toggle

QUINCE THERAPEUTICS INC (QNCX:NASDAQ) absolute price change since previous trading day?

The absolute price change of QUINCE THERAPEUTICS INC (QNCX:NASDAQ) since the previous trading day is $-0.02.


toggle

QUINCE THERAPEUTICS INC (QNCX:NASDAQ) percentage price change since previous trading day?

The percentage price change of QUINCE THERAPEUTICS INC (QNCX:NASDAQ) since the previous trading day is -1.7094%.


toggle

What is the most recent average sentiment score for QUINCE THERAPEUTICS INC (QNCX:NASDAQ)?

The most recent average sentiment score for QUINCE THERAPEUTICS INC (QNCX:NASDAQ) is 64 out of 100.


toggle

What is the most recent average sentiment for QUINCE THERAPEUTICS INC (QNCX:NASDAQ)?

The most recent sentiment for QUINCE THERAPEUTICS INC (QNCX:NASDAQ) is .


SEC-8K** Filing Available For QUINCE THERAPEUTICS INC (QNCX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.